Multiplex assay for the detection of at least two citrus pathogens

ABSTRACT

The present invention provides methods and compositions for detecting multiple citrus pathogens using a multiplex branched DNA signal amplification reaction.

CROSS-REFERENCE TO RELATED APPLICATIONS

This application claims priority benefit of U.S. provisional application No. 61/856,589, filed Jul. 19, 2013, which application is herein incorporated by reference for all purposes.

STATEMENT AS TO RIGHTS TO INVENTIONS MADE UNDER FEDERALLY SPONSORED RESEARCH AND DEVELOPMENT

This invention was made with Government support under Grant No. 58-5302-1-119 and 59-5302-1-226, awarded by the USDA-ARS (Agricultural Research Services). The Government has certain rights in this invention.

REFERENCE TO A SEQUENCE LISTING SUBMITTED AS AN ASCII TEXT FILE

The sequence listing written in file -2155-1PC.TXT, created on Jul. 18, 2014, 48,888 bytes, machine format IBM-PC, MS-Windows operating system, is herein incorporated by reference.

BACKGROUND OF THE INVENTION

Citrus is susceptible to numerous disease caused by plant pathogens. There is a need for efficient and sensitive methods of detecting pathogens.

The method of the present invention provides a method for the detection of multiple, e.g., at least two or at least five, citrus pathogens in a single sample using a multiplex branched signal amplification reaction. The present invention thus provides an accurate, efficient, and quick method of detecting multiple citrus pathogens that is also suitable for high throughput screenings.

BRIEF SUMMARY OF THE INVENTION

The present invention provides methods and kits for detecting at least two citrus DNA pathogen/disease targets where the pathogens are HLB (Huanglongbing, citrus greening, Candidatus Liberibacter asiaticus) and canker (Xanthomonas axonopodis pv. citri). In some embodiments, the methods and kits additionally comprise components for detecting a housekeeping citrus gene, e.g., NADH dehydrogenase gene (Nad5) as an internal control.

Provided herein are specific probes for each of the at two pathogen targets, and methods for detecting the two citrus pathogens and a citrus control gene in a plant sample.

In a further aspect, the present invention provides methods and kits for detecting at least five citrus DNA pathogen/disease targets where the pathogens HLB (Huanglongbing, citrus greening, Candidatus Liberibacter asiaticus), witches' broom (Candidatus Phytoplasma aurantifolia), citrus canker (Xanthomonas axonopodis pv. citri), CVC (Citrus Variegated Chlorosis, Xylella fastidiosa subspecies pauca), and citrus stubborn disease (Spiroplasma citri). In some embodiments, the methods and kits additionally comprise components for detecting a housekeeping citrus gene, e.g., NADH dehydrogenase gene (Nad5) (Citrus sinensis) as an internal control.

Provided herein are specific probes for each pathogen target, and methods for detecting the five citrus pathogens and a citrus control gene in a plant sample.

The methods described herein can be coupled to a procedure for high throughput robotic extraction and purification of nucleic acid targets, optimized for citrus tissues. The methods are user friendly and can be applied for the detection of endemic and/or exotic plant pathogens in quarantine or certification program. Furthermore, the methods can be adopted by monitoring services of plant health status and disease management programs around the world.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 provides illustrative data showing a 3-Plex reaction detecting citrus pathogens.

FIG. 2 illustrates the capability of an 8-Plex assay to detect citrus pathogens.

DETAILED DESCRIPTION OF THE INVENTION

As used herein, a “probe that targets a pathogen” refers to a nucleotide sequence that hybridizes to a desired region of a target nucleic acid in the pathogen.

The term “hybridization” refers to the formation of a duplex structure by two single stranded nucleic acids due to complementary base pairing. Hybridization can occur between exactly complementary nucleic acid strands or between nucleic acid strands that contain minor regions of mismatch. As used herein, the term “substantially complementary” refers to sequences that are complementary except for minor regions of mismatch. Typically, the total number of mismatched nucleotides over a hybridizing region is not more than 3 nucleotides for sequences about 15 nucleotides in length.

The term “probe” refers to an oligonucleotide that selectively hybridizes to a target nucleic acid under suitable conditions. A hybridization assay carried out using a probe under sufficiently stringent hybridization conditions enables the selective detection of a specific target sequence comprising the region of interest of a pathogen nucleic acid. The probe hybridizing region is preferably from about 10 to about 35 nucleotides in length. In some embodiments, the probe hybridizing region is 15 to about 35 nucleotides in length. The use of modified bases or base analogues which affect the hybridization stability, which are well known in the art, may enable the use of shorter or longer probes with comparable stability. The term “nucleotide” thus encompasses naturally occurring nucleotides and nucleotide analogs.

The term “target sequence” or “target region” refers to a region of a nucleic acid in a pathogen of interest to which a probe to the pathogen binds.

A “capture extender probe” or “CE probe” as used here is a polynucleotide that is capable of hybridizing to a nucleic acid of interest from a citrus pathogen and to a capture probe. The capture extender probe has a first polynucleotide sequence that is complementary to a capture probe, and a second polynucleotide sequence, e.g., a sequence as shown in Table 1, which is complementary to a citrus pathogen nucleic acid as described herein. The capture probe is typically immobilized to a solid support, including but not limited to a chip (e.g., an array), well, bead, or other solid support or matrix.

A “label extender probe” or “LE” as used here is a polynucleotide that is capable of hybridizing to a nucleic acid of interest from a pathogen and to a label probe system. The label extender probe has a first polynucleotide sequence that is complementary to a polynucleotide sequence of the label probe system and a second polynucleotide sequence, e.g., a sequence as shown in Table 1, which is complementary to a citrus pathogen as described herein. The signal-amplifying probe in the present invention typically comprises branched DNA, e.g., may include a pre-Amplifier probe, an Amplifier probe, and a Label probe.

Introduction

The present invention provides methods to diagnose infection with citrus pathogens. In some embodiments, the methods can be used in high-throughput screenings of thousands of plant samples in regulatory and research programs. Branched DNA technology (bDNA) employs a sandwich nucleic acid hybridization assay for nucleic acid detection and quantification that amplifies the reporter signal rather than the target sequence of interest that is to be detected. Thus, bDNA technology amplifies signal directly from captured target DNA without purification or reverse transcription. DNA quantitation is performed directly from a tissue sample. By measuring the nucleic acid at the sample source, the assay avoids variations or errors inherent to extraction and amplification of target polynucleotides. The QuantiGene Plex technology can be combined with multiplex bead based assay system such as the Luminex system described below to enable simultaneous detection of multiple pathogens of interest.

In brief in an assay of the invention, a target nucleic acid to be detected is released from cells and captured by a Capture Probe (CP) on a solid surface (e.g., a well of a microtiter plate) through synthetic oligonucleotide probes called Capture Extenders (CEs). Each capture extender has a first polynucleotide sequence that can hybridize to the target nucleic acid and a second polynucleotide sequence that can hybridize to the capture probe. Typically, two or more capture extenders are used. Probes of another type, called Label Extenders (LEs), hybridize to different sequences on the target nucleic acid and to sequences on an amplification multimer. Additionally, Blocking Probes (BLs), which hybridize to regions of the target nucleic acid not occupied by CEs or LEs, are typically used to reduce non-specific target probe binding. A probe set for a given nucleic acid thus has CEs, LEs, and typically BLs for the target citrus pathogen. The CEs, LEs, and BLs are complementary to nonoverlapping sequences in the target nucleic acid from the citrus pathogen, and are typically, but not necessarily, contiguous.

Signal amplification begins with the binding of the LEs to the target DNA. An amplification multimer is then typically hybridized to the LEs. The amplification multimer has multiple copies of a sequence that is complementary to a label probe (it is worth noting that the amplification multimer is typically, but not necessarily, a branched-chain nucleic acid; for example, the amplification multimer can be a branched, forked, or comb-like nucleic acid or a linear nucleic acid). A label, for example, alkaline phosphatase, is covalently attached to each label probe. Alternatively, the label can be noncovalently bound to the label probes. In the final step, labeled complexes are detected, e.g., by the alkaline phosphatase-mediated degradation of a chemilumigenic substrate, e.g., dioxetane. Luminescence is reported as relative light unit (RLUs) on a microplate reader. The amount of chemiluminescence is proportional to the level of DNA in the sample.

The present invention provides a method and compositions for detecting the presence or absence of at least one or two of the citrus pathogens described herein. As explained above, detection is performed using bDNA signal amplification technology and capture extender probes and label extender probes that target the pathogen nucleic acid regions described herein. The general design of branched amplification assays, e.g., suitable amplification multimers, considerations in designing capture probes that bind to the capture extenders, etc.; configuration; and hybridization conditions for such reactions can be determined using methods known in the art (see, e.g., U.S. Patent Application Publication No. 20120003648 and the references cited therein).

Citrus Pathogen Probes

Probes to the five pathogen targets and exemplar internal citrus gene were developed based on specific genomic sequences and characteristics in the pathogens' genome. The probes (Table 1) included Capture Extenders (CE), Label Extenders (LE), Blocking Probes (BL) as per manufacturer's recommendations were designed and developed based on the conserved sequences in the genome of each pathogen. Probes for HLB, Witches' broom, citrus canker, CVC, citrus stubborn disease, and Nad5 were based on target sequence alignment from data deposited in GenBank.

The present invention employs CE and LE probes that comprise sequences presented in Table 1 or are variants of the sequences in Table 1 that retain the ability to hybridize to the same target nucleic acid sequence as the probes shown in Table 1 such that the presence of the pathogen in a plant sample can be detected. Such variant probe sequences typically have no more than 1, 2, 3, 4, 5, 6, 7, or 8 nucleotide changes relative to a probe sequence as shown in Table 1. In some embodiments, a variant probe useful in the invention comprises at least 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, or 20, or more, contiguous nucleotides of a sequence shown in Table 1.

The methods and compositions for detecting single or multiple citrus pathogens as described herein may also include probes to detect a control nucleic acid sequence. In some embodiments, the control is a housekeeping gene that is common to citrus plants. In some embodiments, the housekeeping gene is NADH dehydrogenase gene (abbreviated herein as NAD). In some embodiments, the CE and LE probes comprises the NAD sequences shown in Table 1 or are variants of the sequences that retain the ability to hybridize to the target region in the NAD sequence. In some embodiments, such a variant probe comprises at least 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, or 20, or more, contiguous nucleotides of a sequence shown in Table 1; or has no more than 1, 2, 3, 4, 5, 6, 7, or 8 nucleotide changes relative to the sequence shown in Table 1.

In some embodiments, one or more blocking probes may be employed. Table 1 provides examples of sequences that may be employed in block probes useful in the invention.

In some embodiments, multiple capture extender and/or label extender probes shown in Table 1, or variants thereof as described herein, are used in the invention. In some embodiments, each of the probes that target a pathogen is shown in Table 1. In some embodiments, all of the capture extender and label extender probes shown in Table 1 for a given pathogen, or variants as described herein, are used in the methods, kits, and reactions of the invention for detecting the pathogen. In some embodiments, all of the probes, including any blocking probes, shown in Table 1, or variants thereof as described herein, for a given pathogen are used in the methods, kits, and reactions of the invention. Thus for example, in some embodiments of the invention, all of the probes shown in Table 1 to detect the presence or absence of HLB are used in the invention. In some embodiments, all of the probes shown in Table 1 to detect the presence or absence of Witches' broom are used in the invention. In some embodiments, all of the probes shown in Table 1 to detect the presence or absence of citrus canker are used in the invention. In some embodiments, all of the probes shown in Table 1 to detect the presence or absence of CVC are used in the invention. In some embodiments, all of the probes shown in Table 1 to detect the presence or absence of citrus stubborn disease are used in the invention. In some embodiments, the invention employs all of the probes shown in Table 1 for detecting the presence or absence of HLB, all of the probes shown in Table 1 for detecting the presence or absence of witches' broom, all of the probes shown in Table 1 for detecting the presence or absence of citrus canker, all of the probes shown in Table 1 for detecting the presence or absence of CVC, and all of the probes shown in Table 1 for detecting the presence of absence of citrus stubborn disease in a single reaction mixture. In some embodiments, the invention further employs all of the probes shown in Table 1 to detect the presence of the housekeeping gene NAD. In some embodiments, the invention provides methods, reaction mixtures, and kits that comprise all of the pathogen probes shown in Table 1 and all of the probes shown in Table 1 for detecting the control.

Plant Samples

The sample evaluated for the presence of citrus pathogens can be from any plant material (e.g., seed, foliage, limbs, trunk, bark, rootstock, fruit, germplasm, propagule, cuttings, and budwood). DNA is extracted using well-known techniques. Such a DNA sample may also comprise RNA. Methods for extracting DNA from a plant samples are known to those skilled in the art and are described in Bilgin et al., Nature Protocols, 4:333-340, (2009); Berendzen et al., Plant Methods, 1:4 (2005); Elspeth MacRae, Methods in Molecular Biology, vol. 353: Protocols for Nucleic Acid Analysis by Nonradioactive Probes, Second Edition, Humana Press, New Jersey, 15-24, (2007). Non-limiting examples of commercially available plant DNA extraction kits include DNAeasy Plant Mini Kit (Qiagen, Hilden, Germany), PrepEase DNA Isolation Kit (Affymetrix, Santa Clara, Calif.), PureLink® Genomic Plant DNA Purification Kit (Life Technologies, Carlsbad, Calif.), and Plant/Fungi DNA Isolation kit (Sigma-Aldrich, St. Louis, Mo.).

The following examples are offered to illustrate, but not to limit, the claimed invention.

EXAMPLES High Throughput Assays for Rapid and Accurate 3-Plex Detection of Citrus Pathogens

The need to detect and identify multiple plant pathogens simultaneously has led development and adaptation of a new molecular approach for disease diagnosis. Multiplex QuantiGene (Afftmetrix/Panonmics) and Lumninex RNA assays for reliable detection of citrus pathogens were developed. The sequential hybridization-based assay utilizes Luminex magnetic beads and branched DNA (bDNA) signal amplification. A Luminex 200 instrument was used for the read out of fluorescence resulting from positive sequence-specific hybridizations from beads in the flow cytometer. The assay was performed using 96-well plates which allows for direct detection and quantitation of up to 36 RNA or 34 DNA targets per well in one simultaneous assay.

Example 1 provides an illustrative assay with a total of three targets for the simultaneous detection, identification, and quantification for two citrus DNA pathogens/disease (carrying DNA genomes) and one housekeeping citrus gene internal control: HLB (Huanglongbing, citrus greening, Candidatus Liberibacter asiaticus) and citrus canker (Xanthomonas axonopodis pv. citri); and an internal control, NADH dehydrogenase gene (Nad5).

Example 2 provides an illustrative assay with a total of eight targets for the simultaneous detection, identification, and quantification for five citrus DNA pathogens/disease (carrying DNA genomes) and one housekeeping citrus gene internal control: HLB (Huanglongbing, citrus greening, Candidatus Liberibacter asiaticus), Witches' broom (Candidatus Phytoplasma aurantifolia), citrus canker (Xanthomonas axonopodis pv. citri), CVC (Citrus Variegated Chlorosis, Xylella fastidiosa subspecies pauca), and an internal control, Nad5.

Sequences of specific probes including Capture Extenders (CE), Label Extenders (LE), Blocking Probes (BL) were designed and developed for the specific detection of the citrus pathogen targets and a housekeeping citrus gene as an internal control with QuantiGene Plex and Luminex based DNA assay (see, Table 1).

TABLE 1 Capture Extenders (CE), Label Extenders (LE), Blocking Probes (BL) for HLB, Witches' broom, Citrus canker, CVC, citrus stubborn disease, and a housekeeping citrus gene as an internal control (SEQ ID NOS: 1-167). Targets^(a) Probes Probe Sequence (5′→3′) HLB (1) HLB 001 CE tcgcaagattaaaactcaaagga HLB 002 CE ggattagataccctggtagtccac HLB 003 CE agtgtagaggtgaaattcgtagatattc HLB 004 CE cggcgattaagttagaggtgaaat HLB 005 CE gcgtaaagggcgcgtagg HLB 006 CE agcgttgttcggaataactag HLB 007 LE tccgcctggggagtacgg HLB 008 LE cgcacgtaacgcattaagcac HLB 009 LE tgggtggtttaccattcagtgg HLB 010 LE gctgtaaacgatgagtgctagctgt HLB 011 LE aaagcgtggggagcaaaca HLB 012 LE gatactgacgctgaggcgcg HLB 013 LE aaggcggctcactggcct HLB 014 LE ggaggaacaccggtggcg HLB 015 LE ggagaggtgagtggaattccg HLB 016 LE gcctttaatactgattgtctagagttca HLB 017 LE cttcgtgccagcagccg HLB 018 LE gagaagaagccccggctaa HLB 019 BL cccaggctcaaccttggaact HLB (2) HLB 001 CE ctcctgtgggttatagagattacca HLB 002 CE tctcgtctttacccgaacaaaa HLB 003 CE tctccctcactcaattcaagttca HLB 004 CE cagttgttttacgctcaccctc HLB 005 CE gctatacctacagaaccagcgct HLB 006 LE tttgaaatcttttcactagattctttaat HLB 007 LE ggcctttcaccagaaaagaaatat HLB 008 LE cctctttgcaaaatctcgattaat HLB 009 LE tgatcaatcagatactcaatatccactat HLB 010 LE ccgctttacatataaaggagaacct HLB 011 LE ttgatcattcccctcaatttctat HLB 012 LE gctcaatcatggaataattaattgga HLB 013 LE gccatgatacgacgcttagcac HLB 014 LE tgacttcagaaaaataacccgtg HLB 015 LE tgctggcaattgcgaaatat HLB 016 BL cgccgaattacagaatcatacga HLB 017 BL agaatcacataatcggatacatcatt Witches' Witches' Broom 001 CE cgcattttaccgctacacatg Broom Witches' Broom 002 CE tcgggtatcttcgaattaaacaa Witches' Broom 003 CE catgtcaagacctggtaaggtttt Witches' Broom 004 CE gcagtctcgttaaagtcccca Witches' Broom 005 CE gcatgatgatttgacgtgatcc Witches' Broom 006 CE ttgtacccaggtcataaggg Witches' Broom 007 LE cctctggtgttcctccatatattta Witches' Broom 008 LE ccagcaagccgcctacg Witches' Broom 009 LE gtgcctcagcgtcagtaaagac Witches' Broom 010 LE gtttgctccccacgctttc Witches' Broom 011 LE tggactaccagggtatctaatcct Witches' Broom 012 LE cttagtactcatcgtttacggcg Witches' Broom 013 LE cagtaccggtttaacccgaca Witches' Broom 014 LE ggcggagtacttaatgtgttaactt Witches' Broom 015 LE tttcatacttgcgtacgtactactca Witches' Broom 016 LE ggagtcccgtcaattcattaag Witches' Broom 017 LE ccactatattactatagcttcgcaaaaa Witches' Broom 018 LE caccacctgtgtttctgataacct Witches' Broom 019 BL catgatccaccgcttgtgc Witches' Broom 020 BL acgagctgacgacaaccatg Witches' Broom 021 BL ttaggacttaacctacatctcacga Witches' Broom 022 BL gataagggttgcgctcgtt Witches' Broom 023 BL ccataacgtgctggcaactaa Witches' Broom 024 BL tcaccttcctccaatttatcattg Canker Canker 001 CE gctgaccatgccgcatgtg Canker 002 CE cggcgacttcgactatctgc Canker 003 CE ctggagtgccacctggtctc Canker 004 CE ccggcgatatcttcgaaga Canker 005 CE ccgcactacctcaaggcca Canker 006 CE ggcgccatcaccggct Canker 007 CE cctgtcgaccacgccgt Canker 008 LE tggaagaggtcaaggagacgc Canker 009 LE cgtgaatccaagagctatatcgtga Canker 010 LE gagatggcgtcctaccgca Canker 011 LE tcaaggcgcgcatcagc Canker 012 LE gctaaagctgcccaacgtg Canker 013 LE attccgccgcgccgc Canker 014 LE agatcagcctggcctacaaat Canker 015 LE gcctgctggtgttcgtgg Canker 016 LE acggctggagcgcgac Canker 017 LE gcaccgagcgcgtgcg Canker 018 LE tgggcgagcgggtcgg Canker 019 LE ggcggatttcgtttaccgaac Canker 020 LE cgcatcctgcagcaggagg Canker 021 LE agatcgaccgcaagatcctg Canker 022 BL agttgctcggcagcacctt Canker 023 BL cttacgcgcggctggac CVC (1) CVC 001 CE caatccctgatgtttgtgcaga CVC 002 CE gtttgcaatctgtatctgtttctga CVC 003 CE gcttcaaacgctgcaaagtttc CVC 004 CE tccagtacagtggattcctgttg CVC 005 CE ttcccttaagattgttgcaac CVC 006 CE ctgagacttgacaatctgggtagc CYC 007 LE gttgacccatcgacaatccc CVC 008 LE tagcacttgcgcttgagctt CVC 009 LE tttgtgccaattcacgttgc CVC 010 LE acataacgcgcatcctctaact CVC 011 LE tttgatttggagggtgccc CVC 012 LE cctgcatctggctcgtgtaa CVC 013 LE catgatagcttgacgttgcattg CVC 014 LE aaacaaccgaaagcgcacc CVC 015 LE cacgattccatcaattgggg CVC 016 BL cgagtcgcaatctcaatttcga CVC 017 BL tgagcaatagaccgtcgcgt CVC 018 BL cctgctccagttgcgcca CVC 019 BL acgagcctcagtttctacctttt CVC (2) CVC 001 CE tgcatccactacaggcaatttt CVC 002 CE cgattgcgattggtactacgg CVC 003 CE ggttccaaaacggatgggaat CVC 004 CE gcattgctaccatgaatggct CVC 005 CE acttattctatgcgcctaggca CVC 006 CE aaacctggttcttggtgggtc CVC 007 LE cattgacatcaattgccaatgg CVC 008 LE gcgatagcgataggtaatggag CVC 009 LE gccatcggttcaggcaa CVC 010 LE cggctggcatagattcgatt CVC 011 LE ggctagtcgatatttctggtgca CVC 012 LE cttatatgtcaatgagggtaaactcg CVC 013 LE cagagtattccctgttttatgattatag CVC 014 LE caagccagatttcacgcaaa CVC 015 LE cattcatagtgcttctaacgataaatg CVC 016 LE gctcaagtctatgtaaattccgactc CVC 017 LE ggcgacagtagtcagacatcctt CVC 018 LE gactgaaaattgcgtagaaatactg CVC 019 BL gcgatttctatagggaccgg CVC 020 BL cccgttcgcaatctcaagat CVC 021 BL tagcacaggggctgcgtt CVC 022 BL accagcggcgccactg Citrus Stubborn 001 CE ttgtctgacaattcaacaacatattta stubborn Stubborn 002 CE aaataaacattgttggtatgacctaag disease Stubborn 003 CE ctttttctttcttttcgtttatttgt Stubborn 004 CE ttcgctcatatttcaaactgtttg Stubborn 005 CE aagttgactatcacttgctagttgct Stubborn 006 CE ctgtctttgatttgcaaggtaa Stubborn 007 LE aaccatcaagtttttatcccgttt Stubborn 008 LE cctttgattgttgccagttgtg Stubborn 009 LE ggatattgtcgtatccatttgct Stubborn 010 LE tgtttaattgactagcactatacccac Stubborn 011 LE cgatcagcaacagcactcgc Stubborn 012 LE tgacagtttaccattggttttaacc Stubborn 013 LE ttgtcaacggttcggttgc Stubborn 014 LE taactgctcgacaacttgctctt Stubborn 015 LE cgcttggaatttgcgtttt Stubborn 016 LE ttggtatttaccttatcattttgatat Stubborn 017 LE atttaacagtaatgtttactttgtcattt Stubborn 018 LE attgttctgatgtcgcattattgt Stubborn 019 BL ccattatcagtatttcaatattcttttattt Stubborn 020 BL gtcaatttttactatctgcaaaaagat Stubborn 021 BL aacgaaactttatctttctcataattg Stubborn 022 BL ggtttaaactcactttggtttaaaaca NadS Nad 001 CE ggctatatgatctttgcttgcg Nad 002 CE cgttttcatgatagcaaggtgct Nad 003 CE cccctttatttgaatacccaccta Nad 004 CE gatgctatggagggtcccact Nad 005 CE ggattgcatacttggtcaccc Nad 006 CE caatatgagatttaatgccataactctt Nad 007 CE cccagaaattcttggatttcttg Nad 008 LE tagcttattcaacttgcagtcaatta Nad 009 LE tctttcacttaatgaatcacgcg Nad 010 LE ttacagaacgatctaaagagggtca Nad 011 LE tgcggcaaccactggaata Nad 012 LE caggagctacgacgtcattcct Nad 013 LE tttcgggccgtttttaqctctc Nad 014 LE gcatctctaactattcggttagcg Nad 015 LE gcagctactatggtaacagctgg Nad 016 LE ccagtatccgcttcgattcat Nad 017 LE tttcaaacagtagacttttcaacca Nad 018 LE gttgggaaatcggcacagat Nad 019 LE atttgtattttactttttattggtgct Nad 020 BL cggctttgattgttattacttctg Nad 021 BL tttttgctcgtgctagtgcc ^(a)HLB (Huanglongbing, citrus greening,Candidatus Liberibacter asiaticus), Witches' broom (Candidatus Phytoplasma aurantifolia), citrus canker (Xanthomonas axonopodis pv. citri), CVC (Citrus Variegated Chlorosis, Xylella fastidiosa subspecies pauca), citrus stubborn disease (Spiroplasma citri), and a housekeeping citrus gene, NADH dehydrogenase gene (Nad5) as an internal control

The procedure from the QuantiGene Plex DNA Assay User Manual from Affymetrix/Panomics Inc. is provided below.

Capturing Target DNA from Purified DNA or Total Nucleic Acid

-   -   1. Sample and reagent preparation: thaw probe set, blocking         reagent and nucleic acid samples (both RNA and DNA or DNA only),         and place them on ice.     -   2. Prepare 2.5 M NaOH solution.     -   3. Pre-warm lysis mixture at 37° C. for 30 minutes.     -   4. Prepare sample and a working bead mix including nuclease-free         water, lysis mixture, blocking reagent, capture beads, probe         set, according to reaction composition (Table 2).     -   5. Vortex working bead mix for 30 sec, transfer 20 μl to each         well of the hybridization plate.     -   6. Add 80 μl prepared nucleic acid samples (or DNA sample) to         each well of the above plate.     -   7. Seal the hybridization plate with a pressure seal and mount         the plate into the shaking incubator.     -   8. Incubate for 18-22 hours at 54° C. at 600 rpm.     -   9.

TABLE 2 Working Bead Mix Set Up Order of addition Reagent Per well (μl) 1 Sample 40 2 Lysis mixture 18 3 Probe set 5 4 2.5M NaOH solution 5 Room temperature 30 minutes 5 Neutralization Buffer 12 Sample subtotal 80 1 Nuclease-free water 1.8 2 Lysis mixture 15 3 Blocking reagent 2 4 Proteinase K 0.2 5 Capture beads 1 Working bead mix 20 subtotal Total 100

Signal Amplification and Detection of DNA Targets

-   -   1. Place label probe diluent and SAPE diluent to room         temperature. Incubate amplifier diluent at 37° C. for 20         minutes.     -   2. Prepare 200 ml wash buffer including 0.6 ml wash buffer         Component 1, 10 ml wash buffer Component 2 and 189.4 ml         nuclease-free water.     -   3. Add 36 μl pre-amplifier to 12 ml amplifier diluent.     -   4. Take the hybridization plate out of the shaking incubator,         and spin at 240 g for 60 seconds.     -   5. Open the pressure seal, mix with pipette, then transfer the         hybridization mixture to the magnetic separation plate.     -   6. Put the magnetic separation plate on the plate holder of the         plate washer for 60 seconds, then empty the magnetic separation         and wash three times with 100 μl wash buffer.     -   7. Add 100 μl pre-amplifier solution to each well.     -   8. Seal the magnetic separation plate with a foil plate seal and         shake for 60 minutes at 50° C. with 600 rpm.     -   9. Add 36 μl amplifier to 12 ml amplifier diluent.     -   10. Take the magnetic separation plate out of the shaking         incubator.     -   11. Open the foil plate seal.     -   12. Put the magnetic separation plate on the plate holder of the         plate washer for 60 seconds, then empty the magnetic separation         plate and wash three times with 100 μl wash buffer.     -   13. Add 100 μl amplifier solution to each well.     -   14. Seal the magnetic separation plate with a foil plate seal         and shake for 60 minutes at 50° C. with 600 rpm.     -   15. Add 36 L1 label probe to 12 ml label probe diluent.     -   16. Take the magnetic separation plate out of the shaking         incubator and open the foil plate seal.     -   17. Put the magnetic separation plate on the plate holder of the         plate washer for 60 seconds, then empty the magnetic separation         plate and wash three times with 100 μl wash buffer.     -   18. Add 100 μl label probe solution to each well.     -   19. Seal the magnetic separation plate with a foil plate seal         and shake for 60 minutes at 50° C. with 600 rpm.     -   20. Add 36 μl SAPE to 12 ml SAPE diluent.     -   21. Take the magnetic separation plate out of the shaking         incubator and open the foil plate seal.     -   22. Put the magnetic separation plate on the plate holder of the         plate washer for 60 seconds, then empty the magnetic separation         plate and wash three times with 100 μl wash buffer.     -   23. Add 100 μl SAPE solution to each well.     -   24. Seal the magnetic separation plate with a foil plate seal         and shake for 30 minutes at 50° C. with 600 rpm.     -   25. Take the magnetic separation plate out of the shaking         incubator, open the foil plate seal.     -   26. Put the magnetic separation plate on the plate holder of the         plate washer for 60 seconds, then empty the magnetic separation         plate and wash three times with 100 μl SAPE wash buffer.     -   27. Add 130 μl SAPE wash buffer to each well.     -   28. Seal the magnetic separation plate with a foil plate seal         and cover the magnetic separation plate with foil and shake for         2-3 minutes at room temperature with 600 rpm, then use Luminex         instrument to read.

Example 1 High Throughput DNA Assays for Rapid and Accurate 3-Plex Detection of Citrus Pathogens

The assay was performed using samples from healthy and infected citrus plants with HLB, canker, Xylella fastidiosa (XF), stubborn (Spiroplasma citri), Witches' broom (Candidatus Phytoplasma aurantifolia), respectively (FIG. 1) and cell culture of XF. A procedure for high throughput robotic extraction and purification of nucleic acid targets, optimized for citrus tissues, was developed and used with the Luminex-based QuantiGene Plex system to increase uniformity and cost effectiveness of the test. Samples HLB-1 and HLB-2 were detected to show specific positive reactions with HLB, but not other pathogen targets. In addition, samples HLB-1 and HLB-2 were detected to show positive reactions with Nad5, the positive internal control for citrus plants, which could be used to access the DNA extraction quality and to normalize data for accurate quantification of the pathogen populations among samples. Similarly, sample canker was detected to show specific positive reactions with Nad5 and canker, but not other DNA pathogen targets. Finally, the healthy Navel, Valencia sweet orange and Clementine samples showed positive reaction with Nad5 only, but not to any pathogen targets. These data showed that the assay is capable of specific detection of each target including Nad5, HLB and canker.

Sensitivity studies using serial dilutions of different samples, respectively, suggested that those samples, obtained by the high throughput robotic extraction and purification of nucleic acid targets or crude extraction of total nucleic acid, were consistently detected after dilution of up to 100 times or more, respectively.

Example 2 High Throughput DNA Assays for Rapid and Accurate 8-Plex Detection of Citrus Pathogens

This example illustrates that the 8-plex assay can detect 5 citrus pathogens (HLB, Witches' broom, Citrus canker, CVC, citrus stubborn disease) and a citrus housekeeping gene Nad5. The 8-plex assay employs two sets of probes each to detect HLB and CVC, while Witches' broom, citrus canker, and citrus stubborn each employs one set of probes. FIG. 2 illustrates the specificity of the HLB, Witches' broom, citrus canker, CVC, citrus stubborn, and Nad5 probes to its respective targets.

The assay was performed using samples from healthy and infected citrus plants with Huanglongbing, Witches' broom, Citrus canker, CVC, Citrus-stubborn disease, respectively, (FIG. 2). A procedure for high throughput robotic extraction and purification of nucleic acid targets, optimized for citrus tissues, was developed and used with the Luminex-based QuantiGene Plex system to increase uniformity and cost effectiveness of the test. Samples HLB-1 and HLB-2 were detected to show specific positive reactions with HLB, but not other pathogen targets. In addition, samples HLB-1 and HLB-2 were detected to show positive reactions with Nad5, the positive internal control for citrus plants, which could be used to access the DNA extraction quality and to normalize data for accurate quantification of the pathogen populations among samples. Similarly, Witches' broom, citrus canker, CVC, and stubborn samples showed specific positive reactions with Nad5 and their respective targets, but not other DNA pathogen targets. Finally, the healthy Navel sweet orange, mandarin, and Valencia sweet orange variety samples showed positive reaction with Nad5 only and not to any pathogen targets. These data demonstrated that the assay can specifically detect of each target: Nad5, Huanglongbing, Witches' broom, citrus canker, CVC, and citrus stubborn.

Sensitivity studies using serial dilutions of different samples, respectively, suggested that those samples, obtained by the high throughput robotic extraction and purification of nucleic acid targets or crude extraction of total nucleic acid, were consistently detected after dilution of up to 100 times or more, respectively.

All publications, patents, accession numbers, and patent applications cited in this specification are herein incorporated by reference as if each individual publication or patent application were specifically and individually indicated to be incorporated by reference.

Although the foregoing invention has been described in some detail by way of illustration and example for purposes of clarity of understanding, it will be readily apparent to those of ordinary skill in the art in light of the teachings of this invention that certain changes and modifications may be made thereto without departing from the spirit or scope of the appended claims. 

What is claimed is:
 1. A method for detecting the presence or absence a first citrus pathogen selected from a Huanglongbing, Witches' broom, Citrus Variegated Chlorosis (CVC), and citrus stubborn pathogen in a plant sample, the method comprising: extracting DNA from said sample; performing a multiplex branched DNA signal amplification reaction; wherein the reaction comprises at least one capture extender probe and at least one label extender probe that targets the pathogen, wherein the at least one capture extender probe and the at least one label extender probe each comprises at least 8, 9, or 10 contiguous nucleotides of a probe sequence shown in Table 1; and detecting the presence or absence of a signal above background, wherein the presence of the signal is indicative of the presence of the pathogen in the plants sample.
 2. The method of claim 1, wherein the reaction comprises multiple capture extender probes and multiple label extender probes that target the pathogen, wherein each of the multiple capture extender probes and multiple label extender probes that target the pathogen comprise at least 8, 9, or 10 contiguous nucleotides of a probe sequence as shown in Table
 1. 3. The method of claim 1 or claim 2, wherein each probe in the reaction that targets the pathogen comprises a probe sequence set forth in Table
 1. 4. The method of claim 1, wherein the reaction comprises: each capture extender probe, or a variant thereof, shown in Table 1 for the pathogen, wherein the variant comprises at least 8, 9, or 10 contiguous nucleotides of the capture extender probe sequence shown in Table 1; and/or each label extender probe, or a variant thereof, shown in Table 1 for the pathogen, wherein the variant comprises at least 8, 9, or 10 contiguous nucleotides of the label extender probe sequence shown in Table
 1. 5. The method of any one of claims 1 to 4, wherein the reaction further comprises a blocking probe shown in Table 1 for the pathogen, or a variant thereof that comprises at least 8, 9, or 10 contiguous nucleotides of the blocking probe sequence as shown in Table
 1. 6. The method of claim 1, further comprising detecting the presence or absence of a second citrus pathogen, different from the first citrus pathogen, selected from a Huanglongbing, Witches' broom, Citrus canker, CVC, and citrus stubborn pathogen in the plant sample, wherein the reaction comprises at least one capture extender probe and at least one label extender probe that targets the second pathogen wherein the capture extender probe and the label extender probe that target the second pathogen each comprise at least 8, 9, or 10 contiguous nucleotides of a probe sequence as shown in Table
 1. 7. The method of claim 6, wherein the reaction comprises multiple capture extender probes and multiple label extender probes that target the second pathogen, wherein each of the multiple capture extender probes and multiple label extender probes that target the second pathogen comprise at least 8, 9, or 10 contiguous nucleotides of a probe sequence as shown in Table
 1. 8. The method of claim 6 or claim 7, wherein each probe in the reaction that targets the second pathogen comprises a probe sequence as shown in Table
 1. 9. The method of claim 6, wherein the reaction comprises: each capture extender probe, or a variant thereof, shown in Table 1 for the second pathogen, wherein the variant comprises at least 8, 9, or 10 contiguous nucleotides of the capture extender probe sequence shown in Table 1; and/or each label extender probe, or a variant thereof, shown in Table 1 for the second pathogen, wherein the variant comprises at least 8, 9, or 10 contiguous nucleotides of the label extender probe sequence shown in Table
 1. 10. The method of any one of claims 6 to 9, wherein the reaction further comprises a blocking probe shown in Table 1 for the second pathogen, or a variant thereof that comprises at least 8, 9, or 10 contiguous nucleotides of a blocking probe sequence as shown in Table
 1. 11. The method of claim 6, further comprising detecting the presence or absence of a third citrus pathogen, different from the first and second citrus pathogen, selected from a Huanglongbing, Witches' broom, Citrus canker, CVC, and citrus stubborn pathogen in the plant sample, wherein the reaction comprises at least one capture extender probe and at least one label extender probe that targets the third pathogen, wherein the capture extender probe and the label extender probe that target the third pathogen each comprise at least 8, 9, or 10 contiguous nucleotides of a probe sequence as shown in Table
 1. 12. The method of claim 11, wherein the reaction comprises multiple capture extender probes and multiple label extender probes that target the third pathogen, wherein each of the multiple capture extender probes and multiple label extender probes that target the third pathogen comprise at least 8, 9, or 10 contiguous nucleotides of a probe sequence as shown in Table
 1. 13. The method of claim 11 or claim 12, wherein each probe in the reaction that targets the third pathogen comprise a probe sequence as shown in Table
 1. 14. The method of claim 11, wherein the reaction comprises: each capture extender probe, or a variant thereof, shown in Table 1 for the third pathogen, wherein the variant comprises at least 8, 9, or 10 contiguous nucleotides of the capture extender probe sequence shown in Table 1; and/or each label extender probe, or a variant thereof, shown in Table 1 for the third pathogen, wherein the variant comprises at least 8, 9, or 10 contiguous nucleotides of the label extender probe sequence shown in Table
 1. 15. The method of any one of claims 1 to 14, wherein the reaction further comprises a blocking probe shown in Table 1 for the third pathogen, or a variant thereof that comprises at least 8, 9, or 10 contiguous nucleotides of a blocking probe sequence as shown in Table
 1. 16. The method of claim 11, further comprising detecting the presence or absence of a fourth citrus pathogen, different from the first, second and third pathogen, selected from a Huanglongbing, Witches' broom, Citrus canker, CVC, and citrus stubborn pathogen in the plant sample, wherein the reaction comprises at least one capture extender probe and at least one label extender probe that targets the fourth pathogen wherein the capture extender probe and the label extender probe that target the fourth pathogen each comprise at least 8, 9, or 10 contiguous nucleotides of a probe sequence as shown in Table
 1. 17. The method of claim 16, wherein the reaction comprises multiple capture extender probes and multiple label extender probes that target the fourth pathogen, wherein each of the multiple capture extender probes and multiple label extender probes that target the fourth pathogen comprise at least 8, 9, or 10 contiguous nucleotides of a probe sequence as shown in Table
 1. 18. The method of claim 16 or claim 17, wherein each probe in the reaction that targets the fourth pathogen comprises a probe sequence as shown in Table
 1. 19. The method of claim 16, wherein the reaction comprises: each capture extender probe, or a variant thereof, shown in Table 1 for the fourth pathogen, wherein the variant comprises at least 8, 9, or 10 contiguous nucleotides of the capture extender probe sequence shown in Table 1; and/or each label extender probe, or a variant thereof, shown in Table 1 for the fourth pathogen, wherein the variant comprises at least 8, 9, or 10 contiguous nucleotides of the label extender probe sequence shown in Table
 1. 20. The method of any one of claims 16 to 19, wherein the reaction further comprises a blocking probe shown in Table 1 for the fourth pathogen, or a variant thereof that comprises at least 8, 9, or 10 contiguous nucleotides of a blocking probe sequence as shown in Table
 1. 21. The method of claim 1, comprising detecting the presence or absence of each of the five Huanglongbing, Witches' broom, CVC and citrus stubborn pathogens in the plant sample, wherein for each of the five pathogens, the reaction comprises a capture extender probe and a label extender probe, wherein each capture extender probe and each label extender probe comprises at least 8, 9, or 10 contiguous nucleotides of a probe sequence as shown in Table
 1. 22. The method of claim 21, wherein the reaction comprises multiple capture extender probes and multiple label extender probes that target each of the five pathogens, wherein each of the multiple capture extender probes and each of the multiple label extender probes comprises at least 8, 9, or 10 contiguous nucleotides of a probe sequence shown in Table
 1. 23. The method of claim 21 or claim 22, wherein each probe in the reaction that targets the five pathogens comprises a probe sequence shown in Table
 1. 24. The method of claim 21, wherein the reaction comprises each capture extender probe, or a variant thereof, shown in Table 1 for the five pathogens, wherein the variant comprises at least 8, 9, or 10 contiguous nucleotides of the capture extender probe sequence shown in Table 1; and/or each label extender probe, or a variant thereof, shown in Table 1 for the five pathogens, wherein the variant comprises at least 8, 9, or 10 contiguous nucleotides of the label extender probe sequence shown in Table
 1. 25. The method of any one of claims 21 to 24, wherein the reaction comprises at least one blocking probe for at least one of the five pathogens listed in Table 1 or a variant thereof that comprises at least 8, 9, or 10 contiguous nucleotides of a blocking probe sequence shown in Table
 1. 26. The method of claim 25, wherein the reaction comprises all of the blocking probes for the five pathogens listed in Table
 1. 27. The method of any one of claims 1 to 26, wherein the reaction further comprises one of the capture extender probes and one of the label extender probes for Nad5 listed in Table
 1. 28. The method of claim 27, wherein the reaction comprises all of the label extender probes and all of the capture extender probes for Nad5 listed in Table
 1. 29. A reaction mixture for detecting the presence or absence of a first citrus pathogen selected from a Huanglongbing, Witches' broom, CVC, and citrus stubborn pathogen in a plant sample, wherein the reaction mixture comprises at least one capture extender probe and at least one label extender probe that target the pathogen, where the at least one capture extender probe and at least one label extender probe comprise 8, 9, or 10 contiguous nucleotide of a probe sequence as shown in Table
 1. 30. The reaction mixture of claim 29, wherein the reaction mixture comprises multiple capture extender probes and multiple label extender probes that target the pathogen, wherein each of the multiple capture extender probes and multiple label extender probes comprise at least 8, 9, or 10 contiguous nucleotides of a probe sequence as shown in Table
 1. 31. The reaction mixture of claim 29 or claim 30, wherein each probe in the reaction mixture that targets the pathogen comprises a probe sequence set forth in Table
 1. 32. The reaction mixture of claim 29, wherein the reaction mixture comprises each capture extender probe, or a variant thereof, shown in Table 1 for the pathogen, wherein the variant comprises at least 8, 9, or 10 contiguous nucleotides of the capture extender probe sequence shown in Table 1; and/or each label extender probe, or a variant thereof, shown in Table 1 for the pathogen, wherein the variant comprises at least 8, 9, or 10 contiguous nucleotides of the label extender probe sequence shown in Table
 1. 33. The reaction mixture of any one of claims 29 to 32, wherein the reaction mixture further comprises a blocking probe shown in Table 1 for the pathogen, or a variant thereof that comprises at least 8, 9, or 10 contiguous nucleotides of a blocking probe sequence as shown in Table
 1. 34. The reaction mixture of claim 29, further comprising at least one capture extender probe and at least one label extender probe that target a second citrus pathogen, different from the first citrus pathogen, selected from a Huanglongbing, Witches' broom, CVC, and citrus stubborn pathogen, wherein the capture extender probe and the label extender probe that target the second pathogen each comprise at least 8, 9, or 10 contiguous nucleotides of a probe sequence as shown in Table
 1. 35. The reaction mixture of claim 34, wherein the reaction mixture comprises multiple capture extender probes and multiple label extender probes that target the second pathogen, wherein each of the multiple capture extender probes and multiple label extender probes comprise at least 8, 9, or 10 contiguous nucleotides of a probe sequence as shown in Table
 1. 36. The reaction mixture of claim 34 or claim 35, wherein each probe in the reaction mixture that targets the second pathogen comprises a probe sequence as shown in Table
 1. 37. The reaction mixture of claim 34, wherein the reaction mixture comprises each capture extender probe, or a variant thereof, shown in Table 1 for the second pathogen, wherein the variant comprises at least 8, 9, or 10 contiguous nucleotides of the capture extender probe sequence shown in Table 1; and/or each label extender probe, or a variant thereof, shown in Table 1 for the second pathogen, wherein the variant comprises at least 8, 9, or 10 contiguous nucleotides of the label extender probe sequence shown in Table
 1. 38. The reaction mixture of any one of claims 34 to 37, wherein the reaction mixture further comprises a blocking probe shown in Table 1 for the second pathogen, or a variant thereof that comprises at least 8, 9, or 10 contiguous nucleotides of a blocking probe sequence as shown in Table
 1. 39. The reaction mixture of claim 34, further comprising at least one capture extender probe and at least one label extender probe that target a third citrus pathogen, different from the first and second citrus pathogen, selected from a Huanglongbing, Witches' broom, CVC, and citrus stubborn pathogen, wherein the capture extender probe and the label extender probe that target the third pathogen each comprise at least 8, 9, or 10 contiguous nucleotides of a probe sequence as shown in Table
 1. 40. The reaction mixture of claim 39, wherein the reaction mixture comprises multiple capture extender probes and multiple label extender probes that target the third pathogen, wherein each of the multiple capture extender probes and multiple label extender probes comprise at least 8, 9, or 10 contiguous nucleotides of a probe sequence as shown in Table
 1. 41. The reaction mixture of claim 39 or claim 40, wherein each probe in the reaction mixture that targets the third pathogen comprises a probe sequence as shown in Table
 1. 42. The reaction mixture of claim 39, wherein the reaction mixture comprises each capture extender probe, or a variant thereof, shown in Table 1 for the third pathogen, wherein the variant comprises at least 8, 9, or 10 contiguous nucleotides of the capture extender probe sequence shown in Table 1; and/or each label extender probe, or a variant thereof, shown in Table 1 for the third pathogen, wherein the variant comprises at least 8, 9, or 10 contiguous nucleotides of the label extender probe sequence shown in Table
 1. 43. The reaction mixture of any one of claims 39 to 42, wherein the reaction mixture further comprises a blocking probe shown in Table 1 for the third pathogen, or a variant thereof that comprises at least 8, 9, or 10 contiguous nucleotides of a blocking probe sequence as shown in Table
 1. 44. The reaction mixture of claim 39, further comprising at least one capture extender probe and at least one label extender probe that target a fourth citrus pathogen, different from the first, second, and third citrus pathogens, selected from a Huanglongbing, Witches' broom, CVC, and citrus stubborn pathogen, wherein the capture extender probe and the label extender probe that target the fourth pathogen each comprise at least 8, 9, or 10 contiguous nucleotides of a probe sequence as shown in Table
 1. 45. The reaction mixture of claim 44, wherein the reaction mixture comprises multiple capture extender probes and multiple label extender probes that target the fourth pathogen, wherein each of the multiple capture extender probes and multiple label extender probes comprise at least 8, 9, or 10 contiguous nucleotides of a probe sequence as shown in Table
 1. 46. The reaction mixture of claim 44 or claim 45, wherein each probe that targets the fourth pathogen comprises a probe sequence as shown in Table
 1. 47. The reaction mixture of claim 44, wherein the reaction mixture comprises each capture extender probe, or a variant thereof, shown in Table 1 for the fourth pathogen, wherein the variant comprises at least 8, 9, or 10 contiguous nucleotides of the capture extender probe sequence shown in Table 1; and/or each label extender probe, or a variant thereof, shown in Table 1 for the fourth pathogen, wherein the variant comprises at least 8, 9, or 10 contiguous nucleotides of the label extender probe sequence shown in Table
 1. 48. The reaction mixture of any one of claims 44 to 47, wherein the reaction mixture further comprises a blocking probe shown in Table 1 for the fourth pathogen, or a variant thereof that comprises at least 8, 9, or 10 contiguous nucleotides of a blocking probe sequence as shown in Table 1
 49. The reaction mixture of claim 29, comprising a capture extender probe and a label extender probe for each of five Huanglongbing, Witches' broom, Citrus Variegated Chlorosis (CVC), and citrus stubborn pathogens, wherein each capture extender probe and each label extender probe comprises at least 8, 9, or 10 contiguous nucleotides of a probe sequence as shown in Table
 1. 50. The reaction mixture of claim 49, comprising multiple capture extender probes and multiple label extender probes that target each of the five pathogens, wherein each of the multiple capture extender probes and each of the multiple label extender probes comprises at least 8, 9, or 10 contiguous nucleotides of a probe sequence shown in Table
 1. 51. The reaction mixture of claim 49 or claim 50, wherein each probe in the reaction mixture that targets the five pathogens comprises a probe sequence shown in Table
 1. 52. The reaction mixture of claim 49, comprising each capture extender probe, or a variant thereof, shown in Table 1 for the five pathogens, wherein the variant comprises at least 8, 9, or 10 contiguous nucleotides of the capture extender probe sequence shown in Table 1; and/or each label extender probe, or a variant thereof, shown in Table 1 for the five pathogens, wherein the variant comprises at least 8, 9, or 10 contiguous nucleotides of the label extender probe sequence shown in Table
 1. 53. The reaction mixture of any one of claims 29 to 52, wherein the reaction mixture comprises all of the blocking probes listed in Table
 1. 54. The reaction mixture of any one of claims 29 to 53, wherein the reaction mixture further comprises one of the capture extender probes and one of the label extender probes for Nad5 listed in Table 1, or all of the capture extender probes and all of the label extender probes for Nad5 listed in Table
 1. 55. A kit for detecting the presence of at least one citrus pathogen selected from a Huanglongbing, Witches' broom, CVC and citrus stubborn pathogen in a plant sample, wherein the kit comprises at least one capture extender probe and at least one label extender probe that target the pathogen, where the at least one capture extender probe and at least one label extender probe comprises 8, 9, or 10 contiguous nucleotide of a probe sequence as shown in Table
 1. 56. The kit of claim 55, wherein the kit comprises multiple capture extender probes and multiple label extender probes that target the pathogen, wherein each of the multiple capture extender probes and multiple label extender probes comprises at least 8, 9, or 10 contiguous nucleotides of a probe sequence as shown in Table
 1. 57. The kit of claim 55 or claim 56, wherein each probe in the kit that targets the pathogen comprises a probe sequence set forth in Table
 1. 58. The kit of claim 55, wherein the kit comprises each capture extender probe, or a variant thereof, shown in Table 1 for the pathogen, wherein the variant comprises at least 8, 9, or 10 contiguous nucleotides of the capture extender probe sequence shown in Table 1; and/or each label extender probe, or a variant thereof, shown in Table 1 for the pathogen, wherein the variant comprises at least 8, 9, or 10 contiguous nucleotides of the label extender probe sequence shown in Table
 1. 59. The kit of any one of claim 55 to 58, further comprising a blocking probe shown in Table 1 for the pathogen, or a variant thereof that comprises at least 8, 9, or 10 contiguous nucleotides of a blocking probe sequence as shown in Table
 1. 60. The kit of claim 55, further comprising at least one capture extender probe and at least one label extender probe that target a second pathogen, different from the first pathogen, selected from a Huanglongbing, Witches' broom, CVC, and citrus stubborn pathogen, wherein the capture extender probe and the label extender probe that target the second pathogen each comprise at least 8, 9, or 10 contiguous nucleotides of a probe sequence as shown in Table
 1. 61. The kit of claim 60, wherein the reaction comprises multiple capture extender probes and multiple label extender probes that target the second pathogen, wherein each of the multiple capture extender probes and multiple label extender probes comprise at least 8, 9, or 10 contiguous nucleotides of a probe sequence as shown in Table
 1. 62. The kit of claim 60 or claim 61, wherein each probe in the kit that targets the second pathogen comprises a probe sequence as shown in Table
 1. 63. The kit of claim 60, wherein the reaction comprises each capture extender probe, or a variant thereof, shown in Table 1 for the second pathogen, wherein the variant comprises at least 8, 9, or 10 contiguous nucleotides of the capture extender probe sequence shown in Table 1; and/or each label extender probe, or a variant thereof, shown in Table 1 for the second pathogen, wherein the variant comprises at least 8, 9, or 10 contiguous nucleotides of the label extender probe sequence shown in Table
 1. 64. The kit of any one of claims 60 to 63, wherein the kit further comprises a blocking probe shown in Table 1 for the second pathogen, or a variant thereof that comprises at least 8, 9, or 10 contiguous nucleotides of a blocking probe sequence as shown in Table
 1. 65. The kit of claim 60, further comprising at least one capture extender probe and at least one label extender probe that target a third pathogen, different from the first and second pathogens, selected from a Huanglongbing, Witches' broom, CVC, and citrus stubborn pathogen, wherein the capture extender probe and the label extender probe that target the third pathogen each comprise at least 8, 9, or 10 contiguous nucleotides of a probe sequence as shown in Table
 1. 66. The kit of claim 65, wherein the kit comprises multiple capture extender probes and multiple label extender probes that target the third pathogen, wherein each of the multiple capture extender probes and multiple label extender probes comprise at least 8, 9, or 10 contiguous nucleotides of a probe sequence as shown in Table
 1. 67. The kit of claim 65 or claim 66, wherein each probe in the kit that targets the third pathogen comprises a probe sequence as shown in Table
 1. 68. The kit of claim 65, wherein the kit each capture extender probe, or a variant thereof, shown in Table 1 for the third pathogen, wherein the variant comprises at least 8, 9, or 10 contiguous nucleotides of the capture extender probe sequence shown in Table 1; and/or each label extender probe, or a variant thereof shown in Table 1 for the third pathogen, wherein the variant comprises at least 8, 9, or 10 contiguous nucleotides of the label extender probe sequence shown in Table
 1. 69. The kit of any one of claims 65 to 68, wherein the kit further comprises a blocking probe shown in Table 1 for the third pathogen, or a variant thereof that comprises at least 8, 9, or 10 contiguous nucleotides of a blocking probe sequence as shown in Table
 1. 70. The kit of claim 65, further comprising at least one capture extender probe and at least one label extender probe that target a fourth pathogen, different from the first, second, and third pathogens, selected from a Huanglongbing, Witches' broom, CVC, and citrus stubborn pathogen, wherein the capture extender probe and the label extender probe that target the fourth pathogen each comprise at least 8, 9, or 10 contiguous nucleotides of a probe sequence as shown in Table
 1. 71. The kit of claim 70, comprising multiple capture extender probes and multiple label extender probes that target the fourth pathogen, wherein each of the multiple capture extender probes and multiple label extender probes comprise at least 8, 9, or 10 contiguous nucleotides of a probe sequence as shown in Table
 1. 72. The kit of claim 70 or claim 71, wherein each probe in the kit that targets the fourth pathogen comprises a probe sequence as shown in Table
 1. 73. The kit of claim 70, wherein the kit comprises each capture extender probe, or a variant thereof, shown in Table 1 for the fourth pathogen, wherein the variant comprises at least 8, 9, or 10 contiguous nucleotides of the capture extender probe sequence shown in Table 1; and/or each label extender probe, or a variant thereof, shown in Table 1 for the fourth pathogen, wherein the variant comprises at least 8, 9, or 10 contiguous nucleotides of the label extender probe sequence shown in Table
 1. 74. The kit of any one of claims 70 to 73, wherein the kit further comprises a blocking probe shown in Table 1 for the fourth pathogen, or a variant thereof that comprises at least 8, 9, or 10 contiguous nucleotides of a blocking probe sequence as shown in Table 1
 75. The kit of claim 55, comprising a capture extender probe and a label extender probe for each of five Huanglongbing, Witches' broom, Citrus Variegated Chlorosis (CVC), and citrus stubborn pathogens, wherein each capture extender probe and each label extender probe comprises at least 8, 9, or 10 contiguous nucleotides of a probe sequence as shown in Table
 1. 76. The kit of claim 75, comprising multiple capture extender probes and multiple label extender probes that target each of the five pathogens, wherein each of the multiple capture extender probes and each of the multiple label extender probes comprises at least 8, 9, or 10 contiguous nucleotides of a probe sequence shown in Table
 1. 77. The kit of claim 75 or 76, wherein each probe in the kit that targets the five pathogens comprises a probe sequence shown in Table
 1. 78. The kit of claim 75, comprising each capture extender probe, or a variant thereof, shown in Table 1 for the five pathogens, wherein the variant comprises at least 8, 9, or 10 contiguous nucleotides of the capture extender probe sequence shown in Table 1; and/or each label extender probe, or a variant thereof, shown in Table 1 for the five pathogens, wherein the variant comprises at least 8, 9, or 10 contiguous nucleotides of the label extender probe sequence shown in Table
 1. 79. The kit of any one of claim 55 to 77, wherein the kit comprises all of the blocking probes listed in Table 1 for the five pathogens.
 80. The kit of any one of claim 55 to 79, wherein the kit further comprises one of the capture extender probes and one of the label extender probes for Nad5 listed in Table 1, or all of the capture extender probes and all of the label extender probes for Nad5 listed in Table
 1. 